Search - tctmd.com

Displaying 101 - 120 of 428

Sort: Relevancy | Date

Presentation TCT 2024

What am I Most Anticipating in Upcoming Clinical Trials?

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

Presenter: Behnood Bikdeli

October 29, 2024

Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Presenter: Tobias Rheude

October 29, 2024

Presentation TCT 2024

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Presenter: Thomas Pilgrim

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 974: Characteristics and Outcomes of Patients Screened out of Tricuspid Transcatheter Edge-to-Edge Repair or Transcatheter Tricuspid Valve Replacement Clinical Trials

Presenter: Tai Pham

October 28, 2024

Presentation TCT 2024

Transcatheter Valve Selection for Redo TAVR and Overview of Clinical Trials

Presenter: Radoslaw Parma

October 28, 2024

Presentation TCT 2024

Clinical Trials in the Post ATTRACT Era: What is the New State of the Art Data and Upcoming Trials Guiding DVT Intervention?

Presenter: Suresh Vedantham

October 28, 2024

Presentation TCT 2024

Interatrial Shunts (IASD): From Theory to Clinical Trials

Presenter: Javed Butler

October 28, 2024

Presentation TCT 2024

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Presenter: Santiago Garcia

October 28, 2024

Advertisement

What am I Most Anticipating in Upcoming Clinical Trials?

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

The EARLY TAVR Trial Editorial Commentary

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 974: Characteristics and Outcomes of Patients Screened out of Tricuspid Transcatheter Edge-to-Edge Repair or Transcatheter Tricuspid Valve Replacement Clinical Trials

Transcatheter Valve Selection for Redo TAVR and Overview of Clinical Trials

Clinical Trials in the Post ATTRACT Era: What is the New State of the Art Data and Upcoming Trials Guiding DVT Intervention?

Interatrial Shunts (IASD): From Theory to Clinical Trials

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content